Additionally, COL1 A1, COL1 A2, and MYLK are markers of fibroblasts (myofibroblasts), which indicates that MSCs may also be reprogrammed by tumor cells into cancer-associated fibroblasts (CAFs), further assisting in malignant progression. The gene discussed is MYLK; the disease is neoplasm.